Related Experiment Video
Updated: Oct 4, 2025

07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
12.6K
Pembrolizumab-Induced Type 1 Diabetes in a 95-Year-Old Veteran With Metastatic Melanoma
Damond B Ng1, Jane Weinreb1,2, Sara-Megumi Rumrill3,4
1Department of Medicine, David Geffen School of Medicine, Los Angeles, California.
Abstract:
Low C-peptide levels should prompt a high suspicion for immune checkpoint inhibitor-induced type 1 diabetes, and initiation of insulin therapy should be strongly considered.

